News
News
- Aduro Biotech Announces Milestone Achieved under Merck Collaboration for Initiation of Phase 2 Trial of Anti-CD27 Agonist MK-5890 in Non-Small Cell Lung Cancer
02/06/2020 / 22:15 - GlobeNewswire - iQSTEL Issues December 2019 Shareholder Letter (Revenues, Reg-A, Debt Restructuring)
12/30/2019 / 18:34 - GlobeNewswire - O-I Announces Receipt of Requisite Consents and Expiration of Consent Solicitations Related to Corporate Modernization
12/12/2019 / 15:20 - GlobeNewswire - RightBRIDGE Product Profiler Upgraded for SEC Reg BI
12/10/2019 / 11:00 - GlobeNewswire - TruCrowd Services Clients OrgHarvest and QwikLeaf Make Strides Admid House Judiciary Committees MORE Act
12/09/2019 / 14:00 - GlobeNewswire - O-I Announces Commencement of Consent Solicitations and Process to Amend Bank Credit Agreement Related to Corporate Modernization
12/04/2019 / 13:30 - GlobeNewswire - No Borders Inc. (OTC: NBDR) Announces $3M Reg A Offering Qualification
11/25/2019 / 16:32 - GlobeNewswire - BANGI to Launch $50m Reg A+ Debt Offering Through TruCrowd Services: Offering Will Be Marketed on Cannabis Funding Portal Fundanna.com
11/13/2019 / 14:13 - Newsfile Corp - Aduro Biotech Announces Presentation of Results from First-in-Human Phase 1 Study of Anti-CD27 Agonist as Monotherapy and in Combination with Pembrolizumab in Patients with Advanced Solid Tumors at the Society for Immunotherapy of Cancer 34th Annual Meeting
11/08/2019 / 22:05 - GlobeNewswire - OrgHarvest Receives SEC Approval to Extend Reg A Offering
11/04/2019 / 14:30 - GlobeNewswire
Real-time